These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3632725)

  • 1. Antipyrine metabolism in cultured rat hepatocytes.
    Chenery RJ; Oldham HG; Standring P; Norman SJ; Jennings P; Mason PA
    Biochem Pharmacol; 1987 Sep; 36(18):3077-81. PubMed ID: 3632725
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition.
    Loft S; Poulsen HE
    Biochem Pharmacol; 1989 Apr; 38(7):1125-36. PubMed ID: 2706012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
    Van Geel CA; Van Bezooijen CF
    Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal effects on antipyrine metabolite kinetics in Aroclor 1254-treated rats.
    Shaw PN; Houston JB
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):232-40. PubMed ID: 3087023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver.
    Slusher LB; Park SS; Gelboin HV; Vesell ES
    Biochem Pharmacol; 1987 Jul; 36(14):2359-67. PubMed ID: 2440440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.
    Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD
    Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine metabolism during hepatic regeneration in the rat.
    Poulsen HE; Pilsgaard H
    Liver; 1985 Aug; 5(4):196-9. PubMed ID: 4058271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipyrine metabolism in female Lewis and Dark Agouti strains of rats, which are extensive and poor metabolizers of debrisoquine, respectively.
    Tanaka E; Kobayashi S; Uchida E; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1989 Mar; 49(3):433-5. PubMed ID: 2747044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on rat liver cytochrome P-450s involved in the metabolism of antipyrine: phenobarbital- and 3-methylcholanthrene-inducible isozymes possessing 4-hydroxylase activity.
    Buppodom P; Koga N; Yamada H; Yoshimura H
    Biochem Pharmacol; 1986 Apr; 35(8):1404-6. PubMed ID: 3964305
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of hypoxia and pregnancy on antipyrine metabolism in isolated perfused rat livers.
    Brouwer KL; Vore M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):584-9. PubMed ID: 4032283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on in vitro antipyrine metabolism by 13C,15N double labeled method.
    Nakagawa A; Nakamura K; Maeda K; Kamataki T; Kato R
    Life Sci; 1987 Jul; 41(2):133-43. PubMed ID: 3298908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of alaproclate on antipyrine metabolite formation in man.
    Teunissen MW; Wahlén A; Vinnars E; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(4):447-52. PubMed ID: 6519152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of velnacrine on the mixed function oxidase system.
    Eccles MJ; Danbury TC; Ford JM; Roberts CJ
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):121-5. PubMed ID: 9248779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crude liver membrane fractions and extracellular matrix components as substrata regulate differentially the preservation and inducibility of cytochrome P-450 isoenzymes in cultured rat hepatocytes.
    Saad B; Scholl FA; Thomas H; Schawalder H; Streit V; Waechter F; Maier P
    Eur J Biochem; 1993 Apr; 213(2):805-14. PubMed ID: 8477751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of metronidazole and antipyrine in hepatocytes isolated from mouse and rat.
    Loft S; Poulsen HE
    Xenobiotica; 1990 Feb; 20(2):185-91. PubMed ID: 2333715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
    Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
    Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cytochrome P-450-dependent oxidation reactions by MAO inhibitors in rat liver microsomes.
    Dupont H; Davies DS; Strolin-Benedetti M
    Biochem Pharmacol; 1987 May; 36(10):1651-7. PubMed ID: 3496099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of antipyrine metabolite formation in rats in vivo.
    Rhodes JC; Hall ST; Houston JB
    Xenobiotica; 1984 Sep; 14(9):677-86. PubMed ID: 6516440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cytochrome P-450 mediated metabolism of antipyrine in the rat at different extents of fluosol-DA hemodilution.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):411-4. PubMed ID: 2343186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.